SSE Ticker: 600771

Guangyuyuan Chinese Herbal Medicine Co., Ltd.

广誉远

Authorized Representative: 张斌

Board: Main A

Industry Classification: Manufacturing

Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands

Post date May 10, 2022 — 13:21 Post Lock

R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com

Post date May 9, 2022 — 04:42 Post Lock

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

Post date May 8, 2022 — 21:55 Post Lock

A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D

Post date May 8, 2022 — 20:56 Post Lock

China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.20% China Universal

Post date May 6, 2022 — 08:59 Post Lock

China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.20% China Universal

Post date May 6, 2022 — 08:58 Post Lock

Sector Changes New Crown Treatment Drug Sales Hot New Crown Drug Concept Stocks Strengthened_Stock News_Market_Zhongjin Online

Post date May 5, 2022 — 12:19 Post Lock

A-share lunch review: Shanghai index rose 1.11% in half a day, and the turnover of Ningde era exceeded 17 billion yuan

Post date May 5, 2022 — 11:56 Post Lock

Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball

Post date May 3, 2022 — 18:04 Post Lock

Guang Yuyuan: State-owned assets show vitality, and operating performance in the first quarter has grown significantly-Business Life-Finance

Post date May 1, 2022 — 14:32 Post Lock

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm

Post date May 1, 2022 — 04:00 Post Lock

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks will increase in revenue and net profit, and BeiGene will become the "loss king"-Stock Channel-Hexun.com

Post date May 1, 2022 — 04:00 Post Lock

China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.63% China Universal

Post date April 30, 2022 — 08:40 Post Lock

China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.63% China Universal

Post date April 30, 2022 — 08:38 Post Lock

Guang Yuyuan: State-owned assets show vitality, and operating performance in the first quarter has grown significantly_Oriental Fortune Net

Post date April 29, 2022 — 21:09 Post Lock

Guang Yuyuan: State-owned assets show vitality, and operating performance in the first quarter has grown significantly

Post date April 29, 2022 — 21:08 Post Lock

4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm

Post date April 25, 2022 — 18:15 Post Lock

Pharmaceutical and Biological Industry Weekly Report: Internal and external disturbances in pharmaceutical stock prices need to continue to select pharmaceutical stocks for layout – yqqlm

Post date April 25, 2022 — 10:45 Post Lock

[Graphic Quarterly Report] China Universal CSI Traditional Chinese Medicine Index (LOF) A Fund 2022 First Quarterly Report Review_Oriental Fortune Network

Post date April 24, 2022 — 12:05 Post Lock

The main capital of 2.224 billion yuan will be withdrawn from the pharmaceutical and biological sector today. Yu Yanshu, Yu Xuezhong, Yu Xubo, Yu Xiuming

Post date April 22, 2022 — 19:21 Post Lock

Want to see more data? Registered subscribers can see all the data.